Astera Labs Inc

ALAB remains in a Stage 4 decline confirmed by a decisive Support Failure pattern. Price trades below sloping 9 and 21 EMAs and the flattening 50 DMA, with rallies repeatedly rejected at those levels, reinforcing a medium-term bearish bias. Short-term conditions favor selling now into resistance around the EMAs. The long-term uptrend is intact above the 200 DMA, but any decisive close below it would threaten structural support.

• ↑Q1 revenue $308.4M (+93% YoY, +14% QoQ) drives momentum
• ↑Q2 guidance $355–365M (up 15–18% sequentially)
• ↓Earnings yield severely negative, implying lofty valuation